Ingredients Eight Capsules Contain: Glucosamine Sulfate (as Glucosamine Sulphate Potassium Chloride Complex) 1500 mg. Methyl Sulfonyl Methane (MSM) 1700 mg. Indian frankincense extract (gum) (Boswellia serrata) 700 mg. Curcumin Phytosome (Curcuma longa extract (root) / Phosphatidylcholine complex) 500 mg. Devil's Claw extract (root) (Harpagophytrum procumbens) 400 mg.

Other Ingredients: Hypromellose (derived from cellulose) capsule. May contain one or more of the following hypoallergenic ingredients to fill space û Leucine, Silicon Dioxide.

Contains ingredients derived from shellfish (crab and/or shrimp) and soy (phytosome).

Suggested Use: Eight capsules daily, or as otherwise directed by a health-care practitioner.

This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.

AR-Encap contains glucosamine derived from shellfish.

AR-Encap contains curcumin phytosome, a plant extract complexed with phosphatidylcholine, which is derived from soy. Phosphatidylcholine contains no soy protein. There are no other soy-based ingredients in AR-Encap.

This product does not contain wheat, gluten, corn, yeast, egg, dairy products, or artificial colors, sweeteners, or flavors. This product also does not contain lactose; palmitic acid; or magnesium, calcium or vegetable stearates.

If pregnant, consult your health-care practitioner before using this product.

INTERACTIONS Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided.

This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure or prevent any disease.